Not Yet Recruiting NA INTERVENTIONAL 1-arm
NCT07444645
PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System
Sponsor: M.D. Anderson Cancer Center
Interventions
Y90 Microsphere Therapy
Updated 1 time since 2026 Last updated: Feb 26, 2026 Started: Aug 1, 2026 Primary completion: Jul 31, 2028 Completion: Jul 31, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Liver and Tumor, this trial is actively recruiting participants. The trial is conducted by M.D. Anderson Cancer Center and has accumulated 1 data snapshot since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- M.D. Anderson Cancer Center
- TriSalus Life Sciences, Inc.
Data source: M.D. Anderson Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .